Mechanistic studies suggested that disturbed TGF-β signaling may also contribute to non-genetic cardiovascular disorders such as atherosclerosis and cardiac fibrosis (Goumans and Ten Dijke, 2018). This evidence concerns the gene TGFB1 and atherosclerosis.